Literature DB >> 10522933

Diagnosis and management of intralabyrinthine schwannomas.

J D Green1, J D McKenzie.   

Abstract

OBJECTIVES/HYPOTHESIS: Describe the symptoms, signs, radiographic findings, and treatment results for four patients with intralabyrinthine schwannoma beginning either primarily within the labyrinth or extending secondarily into the labyrinth from the internal auditory canal. STUDY
DESIGN: Retrospective review.
METHODS: Review of clinic records, operative records, imaging studies with follow-up telephone interview, and when possible, repeat examination.
RESULTS: Four patients with intralabyrinthine schwannoma treated by the first author were identified. Episodic vertigo, indistinguishable from Meniere's disease, was present in all but one of the patients in this study. A progressive unilateral hearing loss was also found in all of the patients. Magnetic resonance imaging revealed tumor isolated to the vestibule in two patients with the cochlea primarily involved in the other two patients. Intracochlear tumor extending into the internal auditory canal had been missed on preoperative imaging in one patient and was found during a translabyrinthine vestibular nerve section. In another patient with an intracanalicular schwannoma, tumor extending into the basal turn of the cochlea was not removed during a translabyrinthine approach to the internal auditory canal. The tumor subsequently recurred, necessitating a transotic approach for removal. A transmastoid/translabyrinthine approach was used to successfully remove tumor in one patient. Another patient with good hearing and no vestibular symptoms at time of this writing is being followed with serial imaging studies. As expected, the three patients who underwent surgery have anacusis in the operated ear and are free of vertigo at follow-up intervals of 12, 26, and 65 months.
CONCLUSIONS: Intralabyrinthine schwannomas are rare tumors with optimal treatment being determined by the symptoms, tumor location, and hearing. Findings of an intralabyrinthine schwannoma on magnetic resonance imaging may be easily overlooked and attributed to inflammatory changes.

Entities:  

Mesh:

Year:  1999        PMID: 10522933     DOI: 10.1097/00005537-199910000-00015

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  13 in total

1.  [Intralabyrinthine schwannomas].

Authors:  J Ebmeyer; J Lautermann; L U Scholtz; H Sudhoff
Journal:  HNO       Date:  2011-02       Impact factor: 1.284

2.  Intralabyrinthine Schwannomas: Disease Presentation, Tumor Management, and Hearing Rehabilitation.

Authors:  Baishakhi Choudhury; Matthew L Carlson; Daniel Jethanamest
Journal:  J Neurol Surg B Skull Base       Date:  2019-03-01

3.  Differential diagnosis and prognosis of T1-weighted post-gadolinium intralabyrinthine hyperintensities.

Authors:  F Dubrulle; R Kohler; C Vincent; P Puech; O Ernst
Journal:  Eur Radiol       Date:  2010-06-10       Impact factor: 5.315

4.  Intralabyrinthine schwannomas: imaging diagnosis and classification.

Authors:  K L Salzman; A M Childs; H C Davidson; R J Kennedy; C Shelton; H R Harnsberger
Journal:  AJNR Am J Neuroradiol       Date:  2011-12-08       Impact factor: 3.825

5.  Dumbbell schwannomas of the internal auditory canal.

Authors:  K L Salzman; H C Davidson; H R Harnsberger; C M Glastonbury; R H Wiggins; S Ellul; C Shelton
Journal:  AJNR Am J Neuroradiol       Date:  2001-08       Impact factor: 3.825

6.  [Intracochlear schwannoma as a cause of a deafness: a case report].

Authors:  S Knipping; A Fabricius; S Kösling; M Bloching
Journal:  HNO       Date:  2007-08       Impact factor: 1.284

Review 7.  Meta-analysis on the clinical outcomes in patients with intralabyrinthine schwannomas: conservative management vs. microsurgery.

Authors:  Émilie Gosselin; Anastasios Maniakas; Issam Saliba
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-02-12       Impact factor: 2.503

8.  Clinical features of delayed endolymphatic hydrops and intralabyrinthine schwannoma : An imaging-confirmed comparative case series. English version.

Authors:  C Jerin; E Krause; B Ertl-Wagner; R Gürkov
Journal:  HNO       Date:  2017-01       Impact factor: 1.284

9.  [Clinical features of delayed endolymphatic hydrops and intralabyrinthine schwannoma : An imaging-confirmed comparative case series. German version].

Authors:  C Jerin; E Krause; B Ertl-Wagner; R Gürkov
Journal:  HNO       Date:  2016-12       Impact factor: 1.284

10.  Progressive hearing loss in intracochlear schwannoma.

Authors:  Tadashi Nishimura; Hiroshi Hosoi
Journal:  Eur Arch Otorhinolaryngol       Date:  2007-10-12       Impact factor: 2.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.